The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment: 2005 CCNP Young Investigator Award Paper
Open accessAbstract
This paper focuses on serotonin transporter 5-HTT imaging to investigate major depressive disorder (MDD) and antidepressant occupancy. Such investigations have only recently been possible as a result of major advances in ligand development. The state of the art method is [11 C] DASB PET or [11 C]-3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile) positron emission tomography. [11 C]DASB is a breakthrough for brain imaging 5-HTT. Compared with previous radioligands, [11 C]DASB offers both high selectivity and a favourable ratio of specific binding relative to free and nonspecific binding. These characteristics contribute to valid, reliable quantitation of the 5-HTT binding potential (BP). The 5-HTT BP can be viewed as an index of 5-HTT density in a medication free state, or unblocked 5-HTT density in a medication-treated state. During major depressive episodes with no other axis I comorbidity, either no difference in regional 5-HTT BP or a trend toward elevated 5-HTT BP is typically found. During major depressive episodes (of MDD) with more severe symptoms of pessimism (dysfunctional attitudes), regional 5-HTT BP is elevated. In subjects with major depressive episodes and comorbid axis I psychiatric illnesses, decreased regional 5-HTT BP is often reported. With selective serotonin reuptake inhibitor (SSRI) treatment at doses that distinguish from placebo in the treatment of major depressive episodes, 5-HTT occupancy is approximately 80%, and there is a strong relation between plasma level and occupancy that is not predictable based on affinity alone. Implications of 5-HTT imaging findings for understanding major depressive disorder and antidepressant treatment will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Dissertation Abstracts International
(2017) · The SHAFR Guide Online · doi:10.1163/2468-1733_shafr_sim010020122 · Cited by 4,159
Nonlinear spatial normalization using basis functions
Ashburner, J., & Friston, K. J. (1999) · Human Brain Mapping · doi:10.1002/(sici)1097-0193(1999)7:4<254::aid-hbm4>3.0.co;2-g · Cited by 1,884
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.559 · Cited by 1,723
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Delgado, P. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170011002 · Cited by 924
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 713
Neurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Ichise, M., Liow, J.-S., Lu, J.-Q., Takano, A., Model, K., Toyama, H., Suhara, T., Suzuki, K., Innis, R. B., & Carson, R. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000085441.37552.ca · Cited by 650
Mann, J. J., Huang, Y.-Y., Underwood, M. D., Kassir, S. A., Oppenheim, S., Kelly, T. M., Dwork, A. J., & Arango, V. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.729 · Cited by 613
Increased Serotonin2 and β-Adrenergic Receptor Binding in the Frontal Cortices of Suicide Victims
Mann, J. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100048007 · Cited by 547
Lesch, K., Wolozin, B. L., Murphy, D. L., & Riederer, P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03522.x · Cited by 536
INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS
Stanley, M., & Mann, J. J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92590-4 · Cited by 529
Meyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A., Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., & Houle, S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.826 · Cited by 517 · cited 10×
“The radiotracer [11C] 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile (DASB) was a major advance because of its selectivity, reversibility, greater specific binding relative to free and nonspecific binding and reliability.(20,21,26,27,34,35,40,43,47) This radiotracer was found to be 3 orders of magnitude…”
InfluentialSelf-citationMalison, R. T., Price, L. H., Berman, R., van Dyck, C. H., Pelton, G. H., Carpenter, L., Sanacora, G., Owens, M. J., Nemeroff, C. B., Rajeevan, N., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00272-8 · Cited by 496
Heinz, A., Jones, D. W., Mazzanti, C., Goldman, D., Ragan, P., Hommer, D., Linnoila, M., & Weinberger, D. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00171-7 · Cited by 466
Incorporating Prior Knowledge into Image Registration
Ashburner, J., Neelin, P., Collins, D. L., Evans, A., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0299 · Cited by 460
Prediction of eventual suicide in psychiatric inpatients by clinical ratings of hopelessness
Beck, A. T., Brown, G., & Steer, R. A. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.57.2.309 · Cited by 448
Stockmeier, C. A., Shapiro, L. A., Dilley, G. E., Kolli, T. N., Friedman, L., & Rajkowska, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07394.1998 · Cited by 429
Relapse of depression after rapid depletion of tryptophan
Smith, K., Fairburn, C., & Cowen, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07044-4 · Cited by 423
Arango, V. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230054009 · Cited by 420
Pollock, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00132-9 · Cited by 415
Serotonin transporter gene polymorphism and antidepressant response
Kim, D. K., Lim, S.-W., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., & Carroll, B. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00042 · Cited by 398
Little, K. Y., McLaughlin, D. P., Zhang, L., Livermore, C. S., Dalack, G. W., McFinton, P. R., DelProposto, Z. S., Hill, E., Cassin, B. J., Watson, S. J., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.207 · Cited by 382
5-HT2and D2Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation
Kapur, S., Zipursky, R. B., Remington, G., Jones, C., DaSilva, J., Wilson, A. A., & Houle, S. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.921 · Cited by 370
Arango, V (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00310-4 · Cited by 368
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R. M., Zea-Ponce, Y., Zoghbi, S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359
Stockmeier, C. A. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00050-5 · Cited by 358
DeRubeis, R. J., Evans, M. D., Hollon, S. D., Garvey, M. J., Grove, W. M., & Tuason, V. B. (1990) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.58.6.862 · Cited by 341
Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V., Hussey, D., Hood, K., & Houle, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1843 · Cited by 340
Self-citationBenmansour, S., Cecchi, M., Morilak, D. A., Gerhardt, G. A., Javors, M. A., Gould, G. G., & Frazer, A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10494.1999 · Cited by 337
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Benkelfat, C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090019003 · Cited by 336
The D ysfunctional Att itude Scale: A Validation Study
Weissman, A. (1979) · ScholarlyCommons (University of Pennsylvania) · Cited by 330
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.730 · Cited by 313
Lower Serotonin Transporter Binding Potential in the Human Brain During Major Depressive Episodes
Parsey, R. V., Hastings, R. S., Oquendo, M. A., Huang, Y.-Y., Simpson, N., Arcement, J., Huang, Y., Ogden, R. T., Van Heertum, R. L., Arango, V., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.52 · Cited by 309
CROW, T. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90100-x · Cited by 308
Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M., & Smeraldi, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00021 · Cited by 308
Hoyer, D., Pazos, A., Probst, A., & Palacios, J. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90903-0 · Cited by 291
Delgado, P. L. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110025005 · Cited by 289
Simons, A. D. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790120049007 · Cited by 286
Higher Expression of Serotonin 5-HT2A Receptors in the Postmortem Brains of Teenage Suicide Victims
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., Ren, X., Pandey, S. C., Pesold, C., Roberts, R. C., Conley, R. R., & Tamminga, C. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.419 · Cited by 281
Houle, S., Ginovart, N., Hussey, D., Meyer, J. H., & Wilson, A. A. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000365 · Cited by 276 · cited 1×
“The radiotracer [11C] 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile (DASB) was a major advance because of its selectivity, reversibility, greater specific binding relative to free and nonspecific binding and reliability.(20,21,26,27,34,35,40,43,47) This radiotracer was found to be 3 orders of magnitude…”
Self-citationTurecki, G., Brière, R., Dewar, K., Antonetti, T., Lesage, A. D., Séguin, M., Chawky, N., Vanier, C., Alda, M., Joober, R., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1456 · Cited by 276
Bel, N., & Artigas, F. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90292-c · Cited by 269
Meyer, J. H., Houle, S., Sagrati, S., Carella, A., Hussey, D. F., Ginovart, N., Goulding, V., Kennedy, J., & Wilson, A. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1271 · Cited by 266
Self-citation5HT2 receptor changes in major depression
Yates, M., Leake, A., Candy, J. M., Fairbairn, A. F., McKeith, I. G., & Ferrier, I. N. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90440-d · Cited by 265
Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm
Meyer, J. H., McMain, S., Kennedy, S. H., Korman, L., Brown, G. M., DaSilva, J. N., Wilson, A. A., Blak, T., Eynan-Harvey, R., Goulding, V. S., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.90 · Cited by 264
Self-citationParsey, R. V., Hastings, R. S., Oquendo, M. A., Hu, X., Goldman, D., Huang, Y.-Y., Simpson, N., Arcement, J., Huang, Y., Ogden, R. T., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.48 · Cited by 262
Frankle, W. G., Lombardo, I., New, A. S., Goodman, M., Talbot, P. S., Huang, Y., Hwang, D.-R., Slifstein, M., Curry, S., Abi-Dargham, A., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.915 · Cited by 262
Decreased Imipramine Binding in the Brains of Patients with Depressive Illness
Perry, E. K., Marshall, E. F., Blessed, G., Tomlinson, B. E., & Perry, R. H. (1983) · British Journal of Psychiatry · doi:10.1192/bjp.142.2.188 · Cited by 261
Neurotransmitter transporters : structure, function, and regulation
Reith, M. E. A. (2002) · Humana Press eBooks · Cited by 255
Wilson, A. A., Ginovart, N., Schmidt, M., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Self-citationBernheimer, H., Birkmayer, W., & Hornykiewicz, O. (1961) · Klinische Wochenschrift · doi:10.1007/bf01487648 · Cited by 240
Bel, N., & Artigas, F. (1993) · Synapse · doi:10.1002/syn.890150310 · Cited by 237
Isolation of a cDNA encoding the human brain serotonin transporter
Lesch, K. P., Wolozin, B. L., Estler, H. C., Murphy, D. L., & Riederer, P. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244919 · Cited by 226
Sequence Analysis of the Serotonin Transporter and Associations with Antidepressant Response
Kraft, J. B., Slager, S. L., McGrath, P. J., & Hamilton, S. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.048 · Cited by 224
Neumeister, A., Konstantinidis, A., Stastny, J., Schwarz, M. J., Vitouch, O., Willeit, M., Praschak-Rieder, N., Zach, J., de Zwaan, M., Bondy, B., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.613 · Cited by 223
Blier, P., & De Montigny, C. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-06-01270.1983 · Cited by 223
Cortés, R., Soriano, E., Pazos, A., Probst, A., & Palacios, J. M. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90282-5 · Cited by 217
Bhagwagar, Z., Hinz, R., Taylor, M., Fancy, S., Cowen, P., & Grasby, P. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1580 · Cited by 214
Zhou, F. C., Tao-Cheng, J.-H., Segu, L., Patel, T., & Wang, Y. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00691-x · Cited by 214
Oliver, J. M., & Baumgart, E. P. (1985) · Cognitive Therapy and Research · doi:10.1007/bf01204847 · Cited by 213
Evidence-based pharmacotherapy of obsessive–compulsive disorder
Fineberg, N. A., & Gale, T. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004675 · Cited by 211
Ginovart, N., Wilson, A. A., Meyer, J. H., Hussey, D., & Houle, S. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200111000-00010 · Cited by 209
Self-citationMcCann, U. D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W. B., Ravert, H. T., Dannals, R. F., & Ricaurte, G. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300736 · Cited by 204
Praschak-Rieder, N., Kennedy, J., Wilson, A. A., Hussey, D., Boovariwala, A., Willeit, M., Ginovart, N., Tharmalingam, S., Masellis, M., Houle, S., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.022 · Cited by 203
Self-citationBr�cke, T., Kornhuber, J., Angelberger, P., Asenbaum, S., Frassine, H., & Podreka, I. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245007 · Cited by 200
Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex
Biver, F., Wikler, D., Lotstra, F., Damhaut, P., Goldman, S., & Mendlewicz, J. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.5.444 · Cited by 197
Cannon, D. M., Ichise, M., Fromm, S. J., Nugent, A. C., Rollis, D., Gandhi, S. K., Klaver, J. M., Charney, D. S., Manji, H. K., & Drevets, W. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.005 · Cited by 197
Mamo, D., Kapur, S., Shammi, C. M., Papatheodorou, G., Mann, S., Therrien, F., & Remington, G. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.818 · Cited by 188
Carroll, F. I., Kotian, P., Dehghani, A., Gray, J. L., Kuzemko, M. A., Parham, K. A., Abraham, P., Lewin, A. H., Boja, J. W., & Kuhar, M. J. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00002a020 · Cited by 187
Hrdina, P. D., Foy, B., Hepner, A., & Summers, R. J. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13363-6 · Cited by 186
Regional distribution of serotonin transporter protein in postmortem human brain
Kish, S. J., Furukawa, Y., Chang, L.-J., Tong, J., Ginovart, N., Wilson, A., Houle, S., & Meyer, J. H. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.10.001 · Cited by 179
Self-citationAn automated method for the extraction of regional data from PET images
Rusjan, P., Mamo, D., Ginovart, N., Hussey, D., Vitcu, I., Yasuno, F., Tetsuya, S., Houle, S., & Kapur, S. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.01.011 · Cited by 177
Szabo, Z., Kao, P. F., Scheffel, U., Suehiro, M., Mathews, W. B., Ravert, H. T., Musachio, J. L., Marenco, S., Kim, S. E., Ricaurte, G. A., et al. (1995) · Synapse · doi:10.1002/syn.890200107 · Cited by 170
Brain Serotonin2 Receptors in Major Depression: A Positron Emission Tomography Study
Yatham, L. N., Liddle, P. F., Shiah, I.-S., Scarrow, G., Lam, R. W., Adam, M. J., Zis, A. P., & Ruth, T. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.850 · Cited by 170
Shioe, K., Ichimiya, T., Suhara, T., Takano, A., Sudo, Y., Yasuno, F., Hirano, M., Shinohara, M., Kagami, M., Okubo, Y., et al. (2003) · Synapse · doi:10.1002/syn.10204 · Cited by 168
Laruelle, M., Vanisberg, M.-A., & Maloteaux, J.-M. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90198-9 · Cited by 166
Prefrontal Cortex 5-HT2 Receptors in Depression: An [18F]Setoperone PET Imaging Study
Meyer, J. H., Kapur, S., Houle, S., DaSilva, J., Owczarek, B., Brown, G. M., Wilson, A. A., & Kennedy, S. H. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1029 · Cited by 165
Self-citationPET Imaging of Serotonin Type 2A Receptors in Late-Life Neuropsychiatric Disorders
Meltzer, C. C., Price, J. C., Mathis, C. A., Greer, P. J., Cantwell, M. N., Houck, P. R., Mulsant, B. H., Ben-Eliezer, D., Lopresti, B., DeKosky, S. T., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1871 · Cited by 163
Mintun, M. A., Sheline, Y. I., Moerlein, S. M., Vlassenko, A. G., Huang, Y., & Snyder, A. Z. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.015 · Cited by 160
Cloning and functional characterization of the human 5‐HT2B serotonin receptor
Schmuck, K., Ullmer, C., Engels, P., & Lübbert, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80590-3 · Cited by 158
Oya, S., Choi, S.-R., Hou, C., Mu, M., Kung, M.-P., Acton, P. D., Siciliano, M., & Kung, H. F. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00084-6 · Cited by 158
Wilson, A. A., Ginovart, N., Hussey, D. F., Meyer, J., & Houle, S. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00316-5 · Cited by 157
Self-citationSerotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652
Ichimiya, T., Suhara, T., Sudo, Y., Okubo, Y., Nakayama, K., Nankai, M., Inoue, M., Yasuno, F., Takano, A., Maeda, J., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01351-8 · Cited by 154
Serotonin Receptors in Suicide Victims with Major Depression
Stockmeier, C., Dilley, G. E., Shapiro, L. A., Overholser, J., Thompson, P., & Meltzer, H. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00170-4 · Cited by 150
Depressive relapses and incomplete recovery from index episode
Faravelli, C., Ambonetti, A., Pallanti, S., & Pazzagli, A. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.7.888 · Cited by 149
Frankle, W. G., Huang, Y. H., Hwang, D. R., Talbot, P. S., Slifstein, M., Heertum, R. V., Abi‐Dargham, A., & Laruelle, M. A. (2004) · PubMed · Cited by 146
The process of change in cognitive therapy and pharmacotherapy for depression
Simons, A. D., Garfield, S. L., & Murphy, G. E. (1984) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198406000-00021 · Cited by 145
Huang, Y. H., Hwang, D., Narendran, R., Sudo, Y., Chatterjee, R., Bae, S.-A., Mawlawi, O. R., Kegeles, L. S., Wilson, A. A., Kung, H. F., et al. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000040948.67415.05 · Cited by 144
Hrdina, P. D., & Vu, T. B. (1993) · Synapse · doi:10.1002/syn.890140410 · Cited by 144
In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.
Parsey, R. V., Kegeles, L. S., Hwang, D., Simpson, N. R., Abi‐Dargham, A., Mawlawi, O. R., Slifstein, M., Heertum, R. L. V., Mann, J. J., & Laruelle, M. A. (2000) · PubMed · Cited by 136
Suhara, T., Takano, A., Sudo, Y., Ichimiya, T., Inoue, M., Yasuno, F., Ikoma, Y., & Okubo, Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.386 · Cited by 128
An introduction to PET and SPECT neuroreceptor quantification models.
Ichise, M., Meyer, J. H., & Yonekura, Y. (2001) · PubMed · Cited by 128
Self-citation?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
Pirker, W., Asenbaum, S., Kasper, S. F., Walter, H., Angelberger, P., Koch, G., Pozzera, A., Deecke, L., Podreka, I., & Br�cke, T. (1995) · Journal of Neural Transmission · doi:10.1007/bf01276462 · Cited by 127
Autoradiographic localization of D1 and D2 dopamine receptors in the human brain
Keyser, J. D., Claeys, A., Backer, J. D., Ebinger, G., Roels, F., & Vauquelin, G. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90758-6 · Cited by 127
Trichard, C., Martinot, M. P., Attar-Levy, D., Recasens, C., Monnet, F. P., & Martinot, J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.4.505 · Cited by 125
SPECT imaging of serotonin2 receptors in depression
D’Haenen, H., Bossuyt, A. M., Mertens, J. J. R., Bossuyt‐Piron, C., Gijsemans, M., & Kaufman, L. (1992) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(92)90018-y · Cited by 123
Cognitive biases and depression.
Dohr, K. B., Rush, A. J., & Bernstein, I. H. (1989) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.98.3.263 · Cited by 122
Willeit, M., Stastny, J., Pirker, W., Praschak-Rieder, N., Neumeister, A., Asenbaum, S., Tauscher, J. T., Fuchs, K., Sieghart, W., Hornik, K., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01123-9 · Cited by 122
Integration of Neurobiology and Psychopathology in a Unified Model of Suicidal Behavior
Mann, J. J., & Arango, V. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199204001-00001 · Cited by 121
Hendricksen, M., Thomas, A. J., Ferrier, I. N., Ince, P., & O’Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1096 · Cited by 121
Parsey, R. V., KENT, J. M., Oquendo, M. A., Richards, M., Pratap, M., Cooper, T. B., Arango, V., & Mann, J. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.010 · Cited by 120
Attar-Levy, D., Martinot, J., Blin, J., Dao-Castellana, M. H., Crouzel, C., Mazoyer, B. M., Poirier, M. F., Bourdel, M., Aymard, N., Syrota, A., et al. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00007-9 · Cited by 116
A dose-finding study of duloxetine based on serotonin transporter occupancy
Takano, A., Suzuki, K., Kosaka, J., Ota, M., Nozaki, S., Ikoma, Y., Tanada, S., & Suhara, T. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0304-0 · Cited by 110
Blin, J., Sette, G., Fiorelli, M., Blétry, O., Elghozi, J. L., Crouzel, C., & Baron, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01229.x · Cited by 107
Newberg, A. B., Amsterdam, J. D., Wintering, N., Plöessl, K., Swanson, R. L., Justine Shults, A., & Alavi, A. A. (2005) · PubMed · Cited by 107
Dreshfield, L. J., Wong, D. T., Perry, K. W., & Engleman, E. A. (1996) · Neurochemical Research · doi:10.1007/bf02527753 · Cited by 106
Austin, M. C., Whitehead, R. E., Edgar, C. L., Janosky, J. E., & Lewis, D. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00289-0 · Cited by 100
Celada, P., & Artigas, F. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00166940 · Cited by 98
Messa, C., Colombo, C., Moresco, R. M., Gobbo, C. L., Galli, L., Lucignani, G., Gilardi, M. C., Rizzo, G., Smeraldi, E., Zanardi, R., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1379-5 · Cited by 97
Blin, J., Pappatà, S., Kiyosawa, M., Crouzel, C., & Baron, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90635-8 · Cited by 94
Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Lundberg, J., Odano, I., Olsson, H., Halldin, C., & Farde, L. (2005) · PubMed · Cited by 94
[Study of Beck's hopelessness scale. Validation and factor analysis].
(1992) · PubMed · Cited by 93
Leake, A., FAIRBAIRN, A. F., McKeith, I. G., & Ferrier, I. N. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90084-3 · Cited by 93
Gordon, I., Weizman, R., & Rehavi, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00770-9 · Cited by 92
Effects of Tryptophan Depletion on the Serotonin Transporter in Healthy Humans
Praschak-Rieder, N., Wilson, A. A., Hussey, D., Carella, A., Wei, C. W., Ginovart, N., Schwarz, M., Zach, J., Houle, S., & Meyer, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.038 · Cited by 92
Self-citationLim, J.-E., Papp, A. C., Pinsonneault, J. K., Sadée, W., & Saffen, D. W. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001797 · Cited by 87
The serotonin transporter in the midbrain of suicide victims with major depression
Bligh-Glover, W. Z., Kolli, T. N., Shapiro-Kulnane, L., Dilley, G. E., Friedman, L., Balraj, E. K., Rajkowska, G., & Stockmeier, C. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00313-3 · Cited by 87
Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
Acton, P. D., Choi, S.-R., Hou, C., Plößl, K., & Kung, H. F. (2001) · PubMed · Cited by 85
Moret, C., & Briley, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00646-x · Cited by 83
Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides
Lawrence, K. M., Paermentier, F. D., Cheetham, S. C., Crompton, M. R., Katona, C., & Horton, R. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)90244-6 · Cited by 83
Selective in vitro and in vivo binding of [125I]ADAM to serotonin transporters in rat brain
Choi, S.-R., Hou, C., Oya, S., Mu, M., Kung, M., Siciliano, M., Acton, P. D., & Kung, H. F. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<403::aid-syn5>3.0.co;2-z · Cited by 82
Talbot, P. S., Frankle, W. G., Hwang, D., Huang, Y. H., Suckow, R. F., Slifstein, M., Abi‐Dargham, A., & Laruelle, M. A. (2004) · Synapse · doi:10.1002/syn.20105 · Cited by 81
Dewar, K. M., Grondin, L., Carli, M., Lima, L., & Reader, T. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09303.x · Cited by 79
Kim, J. S., Ichise, M., Sangare, J., & Innis, R. B. (2006) · PubMed · Cited by 79
McN-5652: a highly potent inhibitor of serotonin uptake.
Shank, R. P., Vaught, J. L., Pelley, K., SETLER, P. E., McComsey, D. F., & MARYANOFF, B. E. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13254-0 · Cited by 79
Kuikka, J. T., Bergstr�m, K. A., Vanninen, E. J., et al. (1993) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00180909 · Cited by 77
Ginovart, N., Wilson, A. A., Meyer, J. H., Hussey, D. F., & Houle, S. (2002) · Synapse · doi:10.1002/syn.10155 · Cited by 75
Self-citationIn vivo regulation of the serotonin-2 receptor in rat brain
Stockmeier, C. A., & Kellar, K. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90003-2 · Cited by 73
Evaluation of Serotonergic Transporters using PET and [ 11 C](+)McN-5652: Assessment of Methods
Buck, A., Gucker, P. M., Schönbächler, R., Arigoni, M., Kneifel, S., Vollenweider, X. F., Ametamey, S. M., & Burger, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00005 · Cited by 72
KENT, J. M., Coplan, J. D., Lombardo, I., Hwang, D., Huang, Y. H., Mawlawi, O. R., Heertum, R. V., Slifstein, M., Abi‐Dargham, A., Gorman, J. M., et al. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1218-8 · Cited by 71
[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET
Halldin, C., Lundberg, J., Sóvágó, J., Gulyás, B. Z., Guilloteau, D., Vercouillie, J., Emond, P., Chalon, S., Tarkiainen, J., Hiltunen, J. O., et al. (2005) · Synapse · doi:10.1002/syn.20189 · Cited by 68
Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum
Roth, B. L., McLean, S., Zhu, X., & Chuang, D. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb02444.x · Cited by 66
Georgotas, A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800340057008 · Cited by 66
Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide
Little, K. Y., McLauglin, D. P., Ranc, J., Gilmore, J. H., López, J. F., Watson, S. J., Carroll, F. I., & Butts, J. D. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00301-0 · Cited by 64
Laruelle, M. A., Giddings, S. S., Zea‐Ponce, Y., Charney, D. S., Neumeyer, J. L., Baldwin, R. M., & Innis, R. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030978.x · Cited by 62
Kung, M., Hou, C., Oya, S., et al. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050458 · Cited by 62
Herold, N., Uebelhack, K., Franke, L., Amthauer, H., Luedemann, L., Bruhn, H., Felix, R., Uebelhack, R., & Plotkin, M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0429-7 · Cited by 61
Biology of schizophrenia and affective disease
Alarcón, R. D. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:2<112::aid-da9>3.0.co;2-h · Cited by 59
Fischman, A. J., Bonab, A. A., Babich, J. W., Alpert, N. M., Rauch, S. L., Elmaleh, D. R., Shoup, T. M., Williams, S. A., & Rubin, R. H. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21208-3 · Cited by 59
Alterations in Monoamine Receptors in the Brain of Suicide Victims
Arango, V., Underwood, M. D., & Mann, J. J. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199204001-00002 · Cited by 57
Chalon, S., Tarkiainen, J., Garreau, L., Hall, H., Emond, P., Vercouillie, J., Farde, L., Dasse, P., Varnas, K., Besnard, J.-C., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042226 · Cited by 56
Characteristics of depressed patients with elevated levels of dysfunctional cognitions
Norman, W. H., Miller, I. W., & Dow, M. G. T. (1988) · Cognitive Therapy and Research · doi:10.1007/bf01172779 · Cited by 56
In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment
Tauscher, J. T., Pirker, W., de Zwaan, M., Asenbaum, S., Brücke, T., & Kasper, S. F. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00013-3 · Cited by 56
Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site
Kilbourn, M. R., Sherman, P. S., & Pisani, T. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90216-q · Cited by 55
Biology of schizophrenia and affective disease
Watson, S. J., & Meeting, M. D. (1996) · American Psychiatric Press eBooks · Cited by 54
Regulation of Antidepressant-Sensitive Serotonin Transporters
Blakely, R., Ramamoorthy, S., Qian, Y., Schroeter, S., & Bradley, C. C. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-470-2_2 · Cited by 54
Cannon, B., Mulroy, R., Otto, M. W., Rosenbaum, J. F., D, M. F. M., & Nierenberg, A. A. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00123-2 · Cited by 54
Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study
Erlandsson, K., Sivananthan, T., Lui, D., Spezzi, A., Townsend, C., Mu, S., Lucas, R., Warrington, S., & Ell, P. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1912-y · Cited by 54
Lundberg, J., Halldin, C., & Farde, L. (2006) · Synapse · doi:10.1002/syn.20297 · Cited by 53
Modulation of [3H]mazindol binding sites in rat striatum by dopaminergic agents
Ikawa, K., Watanabe, A., Kaneno, S., & Toru, M. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90390-4 · Cited by 51
Serotonin depletion decreases serotonin transporter mRNA levels in rat brain
Línnet, K., Koed, K., Wiborg, O., & Gregersen, N. (1995) · Brain Research · doi:10.1016/0006-8993(95)00906-7 · Cited by 50
Catafau, A. M., Pérez, V., Penengo, M. M., Bullich, S., Danùs, M., Puigdemont, D., Pascual, J. C., Corripio, I., Llop, J., Perich, J., et al. (2005) · PubMed · Cited by 50
Compan, V., Ségu, L., Buhot, M.-C., & Daszuta, A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00316-3 · Cited by 49
Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain
Ferrer, A., & Artigas, F. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90717-x · Cited by 48
Relapse of depression after rapid depletion of tryptophan
Leyton, M., Young, S. N., & Benkelfat, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61726-6 · Cited by 48
Meyer, J. H., Cho, R., Kennedy, S. H., & Kapur, S. (1999) · Psychopharmacology · doi:10.1007/s002130051004 · Cited by 47
Self-citationPostmortem Stability of Monoamines, Their Metabolites, and Receptor Binding in Rat Brain Regibns
Kontur, P. J., Al‐Tikriti, M. S., Innis, R. B., & Roth, R. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010282.x · Cited by 45
Distribution and characterization of [3H]mesulergine binding in human brain postmortem
Marazziti, D., Rossi, A., Giannaccini, G., Zavaglia, K. M., Dell’Osso, L., Lucacchini, A., & Cassano, G. B. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00045-0 · Cited by 44
Todd, K. G., McManus, D. J., & Baker, G. B. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02089946 · Cited by 43
What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
Kish, S. J. (2003) · Movement Disorders · doi:10.1002/mds.10643 · Cited by 37
Petit-Taboué, M.-C., Landeau, B., Osmont, A., Tillet, I., Barré, L., & Baron, J. (1996) · PubMed · Cited by 36
Maziere, B., Crouzel, C., Venet, M., Stulzaft, O., Sanz, G., Ottaviani, M., Sejourne, C., Pascal, O., & Bisserbe, J. C. (1988) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(88)90018-9 · Cited by 34
Klimek, V., Roberson, G., Stockmeier, C. A., & Ordway, G. A. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00045-1 · Cited by 33
Ikoma, Y., Suhara, T., Toyama, H., Ichimiya, T., Takano, A., Sudo, Y., Inoue, M., Yasuno, F., & Suzuki, K. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00013 · Cited by 32
Филипенко, М. Л., Beilina, A. G., Alekseyenko, O. V., Dolgov, V. V., & Kudryavtseva, N. N. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1015238124000 · Cited by 31
Kapur, S., JONES, C., DaSilva, J. N., Wilson, A. A., & Houle, S. (1997) · Nuclear Medicine Communications · doi:10.1097/00006231-199705000-00002 · Cited by 30
Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies
Lundquist, P., Wilking, H., Höglund, A. U., Sandell, J., Bergström, M., Hartvig, P., & Långström, B. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.12.001 · Cited by 28
A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition
O'Regan, D., Kwok, R. P. S., Yu, P. H., Bailey, B. A., Greenshaw, A. J., & Boulton, A. A. (1987) · Psychopharmacology · doi:10.1007/bf00215477 · Cited by 27
The role of activity level and cognition in depressed mood in a university sample
Dobson, K. S., & Joffe, R. (1986) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198603)42:2<307::aid-jclp2270420213>3.0.co;2-j · Cited by 27
Time Course of In Vivo 5-HTT Transporter Occupancy by Fluvoxamine
Takano, A., Suhara, T., Ichimiya, T., Yasuno, F., & Suzuki, K. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203201.34323.d3 · Cited by 25
Bel, N., & Artigas, F. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171038 · Cited by 25
Fairweather, D. B., Pozzo, C., Kerr, J., LAFFERTY, S. V., & Hindmarch, I. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199703/04)12:2<111::aid-hup846>3.0.co;2-m · Cited by 23
Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20
Blin, J., & Crouzel, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10978.x · Cited by 17
Misunderstandings About How to Choose a Reference Region
Meyer, J. H., Wilson, A. A., Ginovart, N., & Houle, S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.007 · Cited by 3
Self-citationCiliax (1999) · doi:10.1002/(sici)1096-9861(19990621)409:1<38::aid-cne4>3.0.co;2-1
Cited by
Neural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
The serotonin theory of depression: a systematic umbrella review of the evidence
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01661-0 · Cited by 960
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Meyer, J. H.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2007-03
- Volume
- 32
- Issue
- 2
- Pages
- 86-102
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W2133787329
- Cited by
- 272
- References
- 184
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.